Geron Corp (NASDAQ:GERN)

2.81
Delayed Data
As of Mar 04
 -0.15 / -5.07%
Today’s Change
1.31
Today|||52-Week Range
4.62
-13.54%
Year-to-Date

Today’s Trading

Previous close2.96
Today’s open2.86
Day’s range2.70 - 2.92
Volume4,432,673
Average volume (3 months)2,795,994
Market cap$465.3M
Dividend yield--
Data as of 03/04/2015

Growth & Valuation

Earnings growth (last year)+44.44%
Earnings growth (this year)+20.00%
Earnings growth (next 5 years)--
Revenue growth (last year)-52.64%
P/E ratioNM
Price/Sales474.30
Price/Book6.47

Competitors

 Today’s
change
Today’s
% change
TRIBTrinity Biotech PLC+0.17+0.92%
ALRPRBAlere Inc0.000.00%
OXFDOxford Immunotec Glo...+0.04+0.28%
QTNTQuotient Ltd-0.02-0.12%
Data as of 03/04/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$1.3M
Annual profit (last year)-$38.4M
Net profit margin-2,991.35%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account